About Trait Bio
Trait Bio is a company based in Los Alamos (United States) founded in 2018. Trait Bio has raised $47.59 million across 8 funding rounds from investors including Btomorrow Ventures, Gotham Green Partners and Green Acre Capital. Trait Bio offers products and services including Water-Soluble Cannabinoids and Research Services.
- Headquarter Los Alamos, United States
- SectorsConsumer
- Website traitbio.com
- Social LinkedIn X
- Legal Name Trait Biosciences Inc
- Total Equity Funding$47.59 M (USD)
in 8 rounds
- Latest Funding Round$3.69 M (USD), Debt – Conventional
Sep 2023
- InvestorsBtomorrow Ventures
& 3 more
Products & Services of Trait Bio
Trait Bio offers a comprehensive portfolio of products and services, including Water-Soluble Cannabinoids and Research Services.
Water-soluble cannabinoids are developed for end-use applications such as food, beverages, supplements, and pet goods.
Research services are provided in areas like microbiology, genetics, biochemistry, and fermentation for the hemp industry.
Funding Insights of Trait Bio
Trait Bio has successfully raised a total of $47.59M across 8 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.69 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $47.6M
- Total Rounds 8
- Last Round Debt – Conventional — $3.7M
- First Round $9.5M
(Sep 2018)
- Investors Count 4
All 8 funding rounds of Trait Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $3.7M | Debt – Conventional | – | – | |
| Nov 2022 | $230,073 | Series A | – | – | – |
| Jul 2022 | $101,934 | Series A | – | – | – |
| Apr 2022 | $209,849 | Series A | – | – | – |
| Jun 2021 | $25.5M | Series A | – | Btomorrow Ventures | |
| Mar 2021 | – | Debt – Conventional | – | – | – |
| Mar 2021 | $12.1M | Series A | – | – | – |
| Sep 2018 | $9.5M | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Trait Bio
Trait Bio has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Btomorrow Ventures, Gotham Green Partners and Green Acre Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in multiple sectors | – | btomorrowv.com | London, United Kingdom | |
Private equity investments are focused on global cannabis enterprises. | – | gothamgreenpartners.com | New York, United States | |
Green Acre Capital is focused on cannabis industry investments. | – | greenacrecapital.ca | Canada | |
- | – | cannaincomefund.ca | - |
Investor details for Trait Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Trait Bio
14 people are tracked at Trait Bio (4 in leadership, 10 in board & advisors).
| Name | Role | Group |
|---|---|---|
Joseph Del Moral | CEO | Leadership |
Kimberly Landry | Vice President Of Development | Leadership |
Kimberly Landry Harrison | Chief Development Officer (CDO) | Leadership |
Hanny Kanafani | President & COO | Leadership |
Pete Carr | Strategic Advisor | Board & advisors |
Ronan Levy | Director | Board & advisors |
David Smalley | Director | Board & advisors |
Lukasz Garbowski | Director | Board & advisors |
David Rosenthal | Director | Board & advisors |
Auroni Majumdar | Strategic Advisor | Board & advisors |
Keith Levy | Strategic Advisor | Board & advisors |
Francisco Omar Holguin | Advisor | Board & advisors |
David S. Kerr | Advisor | Board & advisors |
Edward Cheung | Co-Founder | Board & advisors |
Complete people profiles for Trait Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Trait Bio
3 dated milestones of Trait Bio across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Trait Bio is founded.
- Funding First funding round of $9.5M.
- Funding Latest funding round, Debt – Conventional, of $3.7M.
Similar companies to Trait Bio
10 companies that operate in the same segment as Trait Bio (Cannabis Platforms & Ecosystem Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Legal medical and recreational cannabis products are manufactured. | 2016 | Ann Arbor, Michigan, United States | USD 89.95 M | – | 214 | |
Cannabis is cultivated, processed, and retailed by PharmaCann vertically. | 2014 | Oak Park, Illinois, United States | USD 218.7 M | – | 979 | |
Consumer lawn and garden products and services are provided. | 1868 | Columbus, Ohio, United States | – | USD 3.41 B | 5,300 | |
Provider of cannabis dispensaries, cultivators, CPG brands, and services | – | Denver, Colorado, United States | – | USD 172.45 M | – | |
Provider of cannabis based medical and consumer products | 2016 | New York, New York, United States | USD 13.78 M | USD 17.42 M | – | |
Offers medical & wellness cannabis products sourcing and processing services | 2021 | London, England, United Kingdom | USD 5.32 M | USD 258.08 K | 168 | |
Cannabis extracts and white label solutions are provided globally. | 2016 | United States | USD 13.56 M | – | – | |
Cannabis products are produced, cultivated, branded, and processed. | 2017 | New York, New York, United States | – | – | 2,198 | |
Medicinal cannabis is produced by Blueberries Medical in Colombia. | 2013 | Bogota, Bogota, Colombia | – | USD 228.08 K | – | |
Enzymatic bioconversions are designed for cannabinoid product synthesis. | 2014 | Monrovia, California, United States | – | – | 16 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trait Bio
Trait Bio was founded in 2018.
Trait Bio is headquartered in Los Alamos, United States. It is registered at Los Alamos, New Mexico, United States.
Joseph Del Moral is the current CEO of Trait Bio.
Trait Bio is a funded company, having raised a total of $47.59M across 8 funding rounds to date. The company's 1st funding round was a Seed of $9.51M, raised on Sep 2018.
Developer of water-soluble cannabinoid extraction technologies. It develops and commercializes proprietary technologies for extracting and formulating water-soluble cannabinoids. These technologies offer advantages over oil-based products, including improved clarity, increased dosage capacity, and broader applications across various consumer products such as food and beverages, beauty aids, supplements, and pet goods. The company utilizes advanced bio-molecular science, chemistry, and computational analytics in its research and development processes. It has a strong team of scientists and business professionals with experience in various relevant fields.
Trait Bio offers Water-Soluble Cannabinoids and Research Services.
Trait Bio has 4 investors. Key investors include Btomorrow Ventures, Gotham Green Partners, Green Acre Capital, and CannaIncome Fund.
Trait Bio operates through Trait Biosciences Inc.